Because tumors require angiogenesis to grow larger than 2 mm3 in size [98], inhibiting the angiogenic factor, vascular endothelial growth factor or VEGF, has been used to stunt CaCx tumor vascularization and improve survival [79]. This evidence concerns the gene VEGFA and neoplasm.